To compare efficacy and safety of two , once-daily basal insulin formulations -LSB- insulin lispro protamine suspension ( ILPS ) vs. insulin glargine ( glargine ) -RSB- added to oral antihyperglycaemic medications ( OAMs ) and exenatide BID in suboptimally controlled type @ diabetes ( T@D ) patients .